nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 2C9 Inducers—Carbamazepine—epilepsy syndrome	0.175	0.328	CiPCiCtD
Aprepitant—Cytochrome P450 2C9 Inducers—Phenytoin—epilepsy syndrome	0.156	0.292	CiPCiCtD
Aprepitant—Cytochrome P450 3A4 Inducers—Carbamazepine—epilepsy syndrome	0.109	0.205	CiPCiCtD
Aprepitant—Cytochrome P450 3A4 Inducers—Topiramate—epilepsy syndrome	0.093	0.174	CiPCiCtD
Aprepitant—CYP2C19—epilepsy syndrome	0.0781	1	CbGaD
Aprepitant—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00833	0.0348	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00697	0.0291	CbGbCtD
Aprepitant—CYP3A7—Carbamazepine—epilepsy syndrome	0.00697	0.0291	CbGbCtD
Aprepitant—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00672	0.028	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00625	0.0261	CbGbCtD
Aprepitant—CYP3A7—Phenytoin—epilepsy syndrome	0.00625	0.0261	CbGbCtD
Aprepitant—CYP2C19—Trimethadione—epilepsy syndrome	0.00624	0.0261	CbGbCtD
Aprepitant—CYP2C19—Felbamate—epilepsy syndrome	0.00624	0.0261	CbGbCtD
Aprepitant—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00587	0.0245	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00557	0.0233	CbGbCtD
Aprepitant—CYP3A7—Phenobarbital—epilepsy syndrome	0.00557	0.0233	CbGbCtD
Aprepitant—CYP3A7—Midazolam—epilepsy syndrome	0.00549	0.0229	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00549	0.0229	CbGbCtD
Aprepitant—CYP3A7—Diazepam—epilepsy syndrome	0.00528	0.0221	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00528	0.0221	CbGbCtD
Aprepitant—CYP3A5—Carbamazepine—epilepsy syndrome	0.00523	0.0218	CbGbCtD
Aprepitant—CYP2C9—Trimethadione—epilepsy syndrome	0.00519	0.0217	CbGbCtD
Aprepitant—CYP2C19—Clobazam—epilepsy syndrome	0.00509	0.0213	CbGbCtD
Aprepitant—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00488	0.0204	CbGbCtD
Aprepitant—CYP3A5—Phenytoin—epilepsy syndrome	0.00469	0.0196	CbGbCtD
Aprepitant—CYP2C19—Carbamazepine—epilepsy syndrome	0.00422	0.0176	CbGbCtD
Aprepitant—CYP3A5—Phenobarbital—epilepsy syndrome	0.00418	0.0175	CbGbCtD
Aprepitant—CYP3A5—Midazolam—epilepsy syndrome	0.00412	0.0172	CbGbCtD
Aprepitant—CYP3A5—Diazepam—epilepsy syndrome	0.00396	0.0165	CbGbCtD
Aprepitant—CYP2C19—Primidone—epilepsy syndrome	0.00394	0.0164	CbGbCtD
Aprepitant—CYP1A2—Carbamazepine—epilepsy syndrome	0.00389	0.0162	CbGbCtD
Aprepitant—CYP2C19—Phenytoin—epilepsy syndrome	0.00378	0.0158	CbGbCtD
Aprepitant—CYP1A2—Primidone—epilepsy syndrome	0.00363	0.0152	CbGbCtD
Aprepitant—TACR1—vagus nerve—epilepsy syndrome	0.00359	0.185	CbGeAlD
Aprepitant—CYP2C19—Propofol—epilepsy syndrome	0.00353	0.0147	CbGbCtD
Aprepitant—CYP2C9—Carbamazepine—epilepsy syndrome	0.00351	0.0146	CbGbCtD
Aprepitant—CYP2C19—Phenobarbital—epilepsy syndrome	0.00337	0.0141	CbGbCtD
Aprepitant—CYP2C9—Primidone—epilepsy syndrome	0.00327	0.0137	CbGbCtD
Aprepitant—CYP1A2—Propofol—epilepsy syndrome	0.00326	0.0136	CbGbCtD
Aprepitant—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00325	0.0136	CbGbCtD
Aprepitant—CYP2C19—Diazepam—epilepsy syndrome	0.0032	0.0133	CbGbCtD
Aprepitant—CYP2C9—Phenytoin—epilepsy syndrome	0.00314	0.0131	CbGbCtD
Aprepitant—CYP3A5—Valproic Acid—epilepsy syndrome	0.00312	0.013	CbGbCtD
Aprepitant—CYP2C19—Zonisamide—epilepsy syndrome	0.00312	0.013	CbGbCtD
Aprepitant—CYP1A2—Phenobarbital—epilepsy syndrome	0.00311	0.013	CbGbCtD
Aprepitant—CYP3A4—Trimethadione—epilepsy syndrome	0.00302	0.0126	CbGbCtD
Aprepitant—CYP3A4—Felbamate—epilepsy syndrome	0.00302	0.0126	CbGbCtD
Aprepitant—CYP1A2—Diazepam—epilepsy syndrome	0.00295	0.0123	CbGbCtD
Aprepitant—CYP2C9—Propofol—epilepsy syndrome	0.00293	0.0122	CbGbCtD
Aprepitant—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00284	0.0118	CbGbCtD
Aprepitant—CYP2C9—Phenobarbital—epilepsy syndrome	0.0028	0.0117	CbGbCtD
Aprepitant—TACR3—hindbrain—epilepsy syndrome	0.00271	0.14	CbGeAlD
Aprepitant—CYP2C9—Diazepam—epilepsy syndrome	0.00266	0.0111	CbGbCtD
Aprepitant—CYP3A4—Clonazepam—epilepsy syndrome	0.00257	0.0107	CbGbCtD
Aprepitant—CYP2C19—Valproic Acid—epilepsy syndrome	0.00252	0.0105	CbGbCtD
Aprepitant—CYP3A4—Clobazam—epilepsy syndrome	0.00246	0.0103	CbGbCtD
Aprepitant—CYP1A2—Valproic Acid—epilepsy syndrome	0.00232	0.00971	CbGbCtD
Aprepitant—CYP2C19—Topiramate—epilepsy syndrome	0.00227	0.00949	CbGbCtD
Aprepitant—CYP2C9—Valproic Acid—epilepsy syndrome	0.00209	0.00875	CbGbCtD
Aprepitant—CYP3A4—Rufinamide—epilepsy syndrome	0.00209	0.00874	CbGbCtD
Aprepitant—CYP3A4—Carbamazepine—epilepsy syndrome	0.00204	0.00851	CbGbCtD
Aprepitant—CYP3A4—Primidone—epilepsy syndrome	0.0019	0.00795	CbGbCtD
Aprepitant—CYP3A4—Phenytoin—epilepsy syndrome	0.00183	0.00764	CbGbCtD
Aprepitant—CYP3A4—Propofol—epilepsy syndrome	0.00171	0.00712	CbGbCtD
Aprepitant—CYP3A4—Phenobarbital—epilepsy syndrome	0.00163	0.00681	CbGbCtD
Aprepitant—CYP3A4—Acetazolamide—epilepsy syndrome	0.00163	0.00681	CbGbCtD
Aprepitant—CYP3A4—Midazolam—epilepsy syndrome	0.00161	0.00671	CbGbCtD
Aprepitant—TACR3—brainstem—epilepsy syndrome	0.00155	0.0801	CbGeAlD
Aprepitant—CYP3A4—Diazepam—epilepsy syndrome	0.00155	0.00645	CbGbCtD
Aprepitant—CYP3A4—Zonisamide—epilepsy syndrome	0.00151	0.0063	CbGbCtD
Aprepitant—TACR3—forebrain—epilepsy syndrome	0.0015	0.0774	CbGeAlD
Aprepitant—TACR1—ganglion—epilepsy syndrome	0.00139	0.0714	CbGeAlD
Aprepitant—TACR3—telencephalon—epilepsy syndrome	0.00138	0.0711	CbGeAlD
Aprepitant—CYP3A4—Valproic Acid—epilepsy syndrome	0.00122	0.00509	CbGbCtD
Aprepitant—CYP3A4—Topiramate—epilepsy syndrome	0.0011	0.00459	CbGbCtD
Aprepitant—TACR3—head—epilepsy syndrome	0.000859	0.0443	CbGeAlD
Aprepitant—TACR3—nervous system—epilepsy syndrome	0.000815	0.042	CbGeAlD
Aprepitant—TACR3—central nervous system—epilepsy syndrome	0.000784	0.0404	CbGeAlD
Aprepitant—TACR3—cerebellum—epilepsy syndrome	0.000767	0.0395	CbGeAlD
Aprepitant—TACR3—brain—epilepsy syndrome	0.000623	0.0321	CbGeAlD
Aprepitant—TACR1—brainstem—epilepsy syndrome	0.000602	0.031	CbGeAlD
Aprepitant—TACR1—forebrain—epilepsy syndrome	0.000581	0.03	CbGeAlD
Aprepitant—TACR1—telencephalon—epilepsy syndrome	0.000534	0.0275	CbGeAlD
Aprepitant—TACR1—spinal cord—epilepsy syndrome	0.000374	0.0193	CbGeAlD
Aprepitant—TACR1—head—epilepsy syndrome	0.000333	0.0172	CbGeAlD
Aprepitant—TACR1—nervous system—epilepsy syndrome	0.000315	0.0163	CbGeAlD
Aprepitant—TACR1—central nervous system—epilepsy syndrome	0.000304	0.0157	CbGeAlD
Aprepitant—TACR1—brain—epilepsy syndrome	0.000241	0.0124	CbGeAlD
Aprepitant—CYP3A4—nervous system—epilepsy syndrome	7.12e-05	0.00367	CbGeAlD
Aprepitant—CYP3A4—central nervous system—epilepsy syndrome	6.86e-05	0.00354	CbGeAlD
Aprepitant—Myalgia—Pregabalin—epilepsy syndrome	1.84e-05	0.000217	CcSEcCtD
Aprepitant—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.84e-05	0.000217	CcSEcCtD
Aprepitant—Dizziness—Zonisamide—epilepsy syndrome	1.83e-05	0.000217	CcSEcCtD
Aprepitant—Headache—Diazepam—epilepsy syndrome	1.83e-05	0.000217	CcSEcCtD
Aprepitant—Anxiety—Pregabalin—epilepsy syndrome	1.83e-05	0.000216	CcSEcCtD
Aprepitant—Diarrhoea—Clonazepam—epilepsy syndrome	1.83e-05	0.000216	CcSEcCtD
Aprepitant—Anaemia—Gabapentin—epilepsy syndrome	1.83e-05	0.000216	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.82e-05	0.000215	CcSEcCtD
Aprepitant—Hypotension—Valproic Acid—epilepsy syndrome	1.82e-05	0.000215	CcSEcCtD
Aprepitant—Asthenia—Carbamazepine—epilepsy syndrome	1.82e-05	0.000215	CcSEcCtD
Aprepitant—Diarrhoea—Phenytoin—epilepsy syndrome	1.82e-05	0.000215	CcSEcCtD
Aprepitant—Discomfort—Pregabalin—epilepsy syndrome	1.81e-05	0.000214	CcSEcCtD
Aprepitant—Nausea—Fosphenytoin—epilepsy syndrome	1.81e-05	0.000214	CcSEcCtD
Aprepitant—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.81e-05	0.000213	CcSEcCtD
Aprepitant—Erythema multiforme—Topiramate—epilepsy syndrome	1.81e-05	0.000213	CcSEcCtD
Aprepitant—Angioedema—Gabapentin—epilepsy syndrome	1.81e-05	0.000213	CcSEcCtD
Aprepitant—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.81e-05	0.000213	CcSEcCtD
Aprepitant—Vomiting—Felbamate—epilepsy syndrome	1.8e-05	0.000213	CcSEcCtD
Aprepitant—Dry mouth—Pregabalin—epilepsy syndrome	1.8e-05	0.000212	CcSEcCtD
Aprepitant—Pruritus—Carbamazepine—epilepsy syndrome	1.79e-05	0.000212	CcSEcCtD
Aprepitant—Rash—Felbamate—epilepsy syndrome	1.79e-05	0.000211	CcSEcCtD
Aprepitant—Eye disorder—Topiramate—epilepsy syndrome	1.79e-05	0.000211	CcSEcCtD
Aprepitant—Dermatitis—Felbamate—epilepsy syndrome	1.79e-05	0.000211	CcSEcCtD
Aprepitant—Malaise—Gabapentin—epilepsy syndrome	1.78e-05	0.000211	CcSEcCtD
Aprepitant—Tinnitus—Topiramate—epilepsy syndrome	1.78e-05	0.00021	CcSEcCtD
Aprepitant—Headache—Felbamate—epilepsy syndrome	1.78e-05	0.00021	CcSEcCtD
Aprepitant—Confusional state—Pregabalin—epilepsy syndrome	1.77e-05	0.00021	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.77e-05	0.000209	CcSEcCtD
Aprepitant—Flushing—Topiramate—epilepsy syndrome	1.77e-05	0.000209	CcSEcCtD
Aprepitant—Cardiac disorder—Topiramate—epilepsy syndrome	1.77e-05	0.000209	CcSEcCtD
Aprepitant—Syncope—Gabapentin—epilepsy syndrome	1.77e-05	0.000209	CcSEcCtD
Aprepitant—Dizziness—Clonazepam—epilepsy syndrome	1.77e-05	0.000209	CcSEcCtD
Aprepitant—Nausea—Vigabatrin—epilepsy syndrome	1.77e-05	0.000209	CcSEcCtD
Aprepitant—Vomiting—Zonisamide—epilepsy syndrome	1.76e-05	0.000208	CcSEcCtD
Aprepitant—Insomnia—Valproic Acid—epilepsy syndrome	1.76e-05	0.000208	CcSEcCtD
Aprepitant—Oedema—Pregabalin—epilepsy syndrome	1.76e-05	0.000208	CcSEcCtD
Aprepitant—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.76e-05	0.000208	CcSEcCtD
Aprepitant—Asthenia—Lamotrigine—epilepsy syndrome	1.76e-05	0.000208	CcSEcCtD
Aprepitant—Dizziness—Phenytoin—epilepsy syndrome	1.76e-05	0.000207	CcSEcCtD
Aprepitant—Rash—Zonisamide—epilepsy syndrome	1.75e-05	0.000207	CcSEcCtD
Aprepitant—Infection—Pregabalin—epilepsy syndrome	1.75e-05	0.000206	CcSEcCtD
Aprepitant—Paraesthesia—Valproic Acid—epilepsy syndrome	1.75e-05	0.000206	CcSEcCtD
Aprepitant—Palpitations—Gabapentin—epilepsy syndrome	1.75e-05	0.000206	CcSEcCtD
Aprepitant—Dermatitis—Zonisamide—epilepsy syndrome	1.75e-05	0.000206	CcSEcCtD
Aprepitant—Dizziness—Oxcarbazepine—epilepsy syndrome	1.75e-05	0.000206	CcSEcCtD
Aprepitant—Nausea—Diazepam—epilepsy syndrome	1.74e-05	0.000205	CcSEcCtD
Aprepitant—Loss of consciousness—Gabapentin—epilepsy syndrome	1.74e-05	0.000205	CcSEcCtD
Aprepitant—Headache—Zonisamide—epilepsy syndrome	1.74e-05	0.000205	CcSEcCtD
Aprepitant—Dyspnoea—Valproic Acid—epilepsy syndrome	1.74e-05	0.000205	CcSEcCtD
Aprepitant—Diarrhoea—Carbamazepine—epilepsy syndrome	1.73e-05	0.000205	CcSEcCtD
Aprepitant—Angiopathy—Topiramate—epilepsy syndrome	1.73e-05	0.000205	CcSEcCtD
Aprepitant—Pruritus—Lamotrigine—epilepsy syndrome	1.73e-05	0.000205	CcSEcCtD
Aprepitant—Shock—Pregabalin—epilepsy syndrome	1.73e-05	0.000204	CcSEcCtD
Aprepitant—Somnolence—Valproic Acid—epilepsy syndrome	1.73e-05	0.000204	CcSEcCtD
Aprepitant—Immune system disorder—Topiramate—epilepsy syndrome	1.73e-05	0.000204	CcSEcCtD
Aprepitant—Nervous system disorder—Pregabalin—epilepsy syndrome	1.73e-05	0.000204	CcSEcCtD
Aprepitant—Cough—Gabapentin—epilepsy syndrome	1.73e-05	0.000204	CcSEcCtD
Aprepitant—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.72e-05	0.000203	CcSEcCtD
Aprepitant—Mediastinal disorder—Topiramate—epilepsy syndrome	1.72e-05	0.000203	CcSEcCtD
Aprepitant—Tachycardia—Pregabalin—epilepsy syndrome	1.72e-05	0.000203	CcSEcCtD
Aprepitant—Chills—Topiramate—epilepsy syndrome	1.72e-05	0.000202	CcSEcCtD
Aprepitant—Dyspepsia—Valproic Acid—epilepsy syndrome	1.71e-05	0.000202	CcSEcCtD
Aprepitant—Convulsion—Gabapentin—epilepsy syndrome	1.71e-05	0.000202	CcSEcCtD
Aprepitant—Skin disorder—Pregabalin—epilepsy syndrome	1.71e-05	0.000202	CcSEcCtD
Aprepitant—Hypertension—Gabapentin—epilepsy syndrome	1.71e-05	0.000202	CcSEcCtD
Aprepitant—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.7e-05	0.000201	CcSEcCtD
Aprepitant—Vomiting—Clonazepam—epilepsy syndrome	1.7e-05	0.000201	CcSEcCtD
Aprepitant—Decreased appetite—Valproic Acid—epilepsy syndrome	1.69e-05	0.0002	CcSEcCtD
Aprepitant—Alopecia—Topiramate—epilepsy syndrome	1.69e-05	0.000199	CcSEcCtD
Aprepitant—Vomiting—Phenytoin—epilepsy syndrome	1.69e-05	0.000199	CcSEcCtD
Aprepitant—Rash—Clonazepam—epilepsy syndrome	1.69e-05	0.000199	CcSEcCtD
Aprepitant—Dermatitis—Clonazepam—epilepsy syndrome	1.68e-05	0.000199	CcSEcCtD
Aprepitant—Myalgia—Gabapentin—epilepsy syndrome	1.68e-05	0.000199	CcSEcCtD
Aprepitant—Chest pain—Gabapentin—epilepsy syndrome	1.68e-05	0.000199	CcSEcCtD
Aprepitant—Arthralgia—Gabapentin—epilepsy syndrome	1.68e-05	0.000199	CcSEcCtD
Aprepitant—Nausea—Felbamate—epilepsy syndrome	1.68e-05	0.000199	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Vomiting—Oxcarbazepine—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Fatigue—Valproic Acid—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Anxiety—Gabapentin—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Anorexia—Pregabalin—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Dizziness—Carbamazepine—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Diarrhoea—Lamotrigine—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Headache—Clonazepam—epilepsy syndrome	1.68e-05	0.000198	CcSEcCtD
Aprepitant—Rash—Phenytoin—epilepsy syndrome	1.67e-05	0.000198	CcSEcCtD
Aprepitant—Mental disorder—Topiramate—epilepsy syndrome	1.67e-05	0.000198	CcSEcCtD
Aprepitant—Dermatitis—Phenytoin—epilepsy syndrome	1.67e-05	0.000198	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.67e-05	0.000197	CcSEcCtD
Aprepitant—Rash—Oxcarbazepine—epilepsy syndrome	1.67e-05	0.000197	CcSEcCtD
Aprepitant—Pain—Valproic Acid—epilepsy syndrome	1.67e-05	0.000197	CcSEcCtD
Aprepitant—Constipation—Valproic Acid—epilepsy syndrome	1.67e-05	0.000197	CcSEcCtD
Aprepitant—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.66e-05	0.000196	CcSEcCtD
Aprepitant—Headache—Phenytoin—epilepsy syndrome	1.66e-05	0.000196	CcSEcCtD
Aprepitant—Malnutrition—Topiramate—epilepsy syndrome	1.66e-05	0.000196	CcSEcCtD
Aprepitant—Erythema—Topiramate—epilepsy syndrome	1.66e-05	0.000196	CcSEcCtD
Aprepitant—Discomfort—Gabapentin—epilepsy syndrome	1.66e-05	0.000196	CcSEcCtD
Aprepitant—Headache—Oxcarbazepine—epilepsy syndrome	1.66e-05	0.000195	CcSEcCtD
Aprepitant—Nausea—Zonisamide—epilepsy syndrome	1.65e-05	0.000195	CcSEcCtD
Aprepitant—Dry mouth—Gabapentin—epilepsy syndrome	1.65e-05	0.000194	CcSEcCtD
Aprepitant—Hypotension—Pregabalin—epilepsy syndrome	1.64e-05	0.000194	CcSEcCtD
Aprepitant—Flatulence—Topiramate—epilepsy syndrome	1.64e-05	0.000194	CcSEcCtD
Aprepitant—Dysgeusia—Topiramate—epilepsy syndrome	1.63e-05	0.000192	CcSEcCtD
Aprepitant—Confusional state—Gabapentin—epilepsy syndrome	1.63e-05	0.000192	CcSEcCtD
Aprepitant—Dizziness—Lamotrigine—epilepsy syndrome	1.62e-05	0.000191	CcSEcCtD
Aprepitant—Oedema—Gabapentin—epilepsy syndrome	1.61e-05	0.000191	CcSEcCtD
Aprepitant—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.61e-05	0.000191	CcSEcCtD
Aprepitant—Vomiting—Carbamazepine—epilepsy syndrome	1.61e-05	0.00019	CcSEcCtD
Aprepitant—Back pain—Topiramate—epilepsy syndrome	1.61e-05	0.00019	CcSEcCtD
Aprepitant—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.6e-05	0.000189	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.6e-05	0.000189	CcSEcCtD
Aprepitant—Infection—Gabapentin—epilepsy syndrome	1.6e-05	0.000189	CcSEcCtD
Aprepitant—Muscle spasms—Topiramate—epilepsy syndrome	1.6e-05	0.000189	CcSEcCtD
Aprepitant—Rash—Carbamazepine—epilepsy syndrome	1.6e-05	0.000189	CcSEcCtD
Aprepitant—Dermatitis—Carbamazepine—epilepsy syndrome	1.6e-05	0.000189	CcSEcCtD
Aprepitant—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.59e-05	0.000188	CcSEcCtD
Aprepitant—Insomnia—Pregabalin—epilepsy syndrome	1.59e-05	0.000188	CcSEcCtD
Aprepitant—Nausea—Clonazepam—epilepsy syndrome	1.59e-05	0.000188	CcSEcCtD
Aprepitant—Headache—Carbamazepine—epilepsy syndrome	1.59e-05	0.000188	CcSEcCtD
Aprepitant—Shock—Gabapentin—epilepsy syndrome	1.59e-05	0.000187	CcSEcCtD
Aprepitant—Nervous system disorder—Gabapentin—epilepsy syndrome	1.58e-05	0.000187	CcSEcCtD
Aprepitant—Paraesthesia—Pregabalin—epilepsy syndrome	1.58e-05	0.000187	CcSEcCtD
Aprepitant—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.58e-05	0.000187	CcSEcCtD
Aprepitant—Nausea—Phenytoin—epilepsy syndrome	1.58e-05	0.000186	CcSEcCtD
Aprepitant—Tachycardia—Gabapentin—epilepsy syndrome	1.58e-05	0.000186	CcSEcCtD
Aprepitant—Dyspnoea—Pregabalin—epilepsy syndrome	1.57e-05	0.000185	CcSEcCtD
Aprepitant—Nausea—Oxcarbazepine—epilepsy syndrome	1.57e-05	0.000185	CcSEcCtD
Aprepitant—Skin disorder—Gabapentin—epilepsy syndrome	1.57e-05	0.000185	CcSEcCtD
Aprepitant—Somnolence—Pregabalin—epilepsy syndrome	1.56e-05	0.000185	CcSEcCtD
Aprepitant—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.56e-05	0.000184	CcSEcCtD
Aprepitant—Tremor—Topiramate—epilepsy syndrome	1.56e-05	0.000184	CcSEcCtD
Aprepitant—Vomiting—Lamotrigine—epilepsy syndrome	1.56e-05	0.000184	CcSEcCtD
Aprepitant—Urticaria—Valproic Acid—epilepsy syndrome	1.55e-05	0.000183	CcSEcCtD
Aprepitant—Rash—Lamotrigine—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Ill-defined disorder—Topiramate—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Dermatitis—Lamotrigine—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Abdominal pain—Valproic Acid—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Body temperature increased—Valproic Acid—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Anorexia—Gabapentin—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Anaemia—Topiramate—epilepsy syndrome	1.54e-05	0.000182	CcSEcCtD
Aprepitant—Headache—Lamotrigine—epilepsy syndrome	1.54e-05	0.000181	CcSEcCtD
Aprepitant—Decreased appetite—Pregabalin—epilepsy syndrome	1.53e-05	0.000181	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.52e-05	0.000179	CcSEcCtD
Aprepitant—Fatigue—Pregabalin—epilepsy syndrome	1.52e-05	0.000179	CcSEcCtD
Aprepitant—Hypotension—Gabapentin—epilepsy syndrome	1.51e-05	0.000178	CcSEcCtD
Aprepitant—Nausea—Carbamazepine—epilepsy syndrome	1.51e-05	0.000178	CcSEcCtD
Aprepitant—Constipation—Pregabalin—epilepsy syndrome	1.51e-05	0.000178	CcSEcCtD
Aprepitant—Pain—Pregabalin—epilepsy syndrome	1.51e-05	0.000178	CcSEcCtD
Aprepitant—Malaise—Topiramate—epilepsy syndrome	1.5e-05	0.000177	CcSEcCtD
Aprepitant—Syncope—Topiramate—epilepsy syndrome	1.49e-05	0.000176	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.47e-05	0.000174	CcSEcCtD
Aprepitant—Palpitations—Topiramate—epilepsy syndrome	1.47e-05	0.000174	CcSEcCtD
Aprepitant—Loss of consciousness—Topiramate—epilepsy syndrome	1.46e-05	0.000173	CcSEcCtD
Aprepitant—Insomnia—Gabapentin—epilepsy syndrome	1.46e-05	0.000172	CcSEcCtD
Aprepitant—Nausea—Lamotrigine—epilepsy syndrome	1.46e-05	0.000172	CcSEcCtD
Aprepitant—Cough—Topiramate—epilepsy syndrome	1.45e-05	0.000171	CcSEcCtD
Aprepitant—Feeling abnormal—Pregabalin—epilepsy syndrome	1.45e-05	0.000171	CcSEcCtD
Aprepitant—Paraesthesia—Gabapentin—epilepsy syndrome	1.45e-05	0.000171	CcSEcCtD
Aprepitant—Convulsion—Topiramate—epilepsy syndrome	1.44e-05	0.00017	CcSEcCtD
Aprepitant—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.44e-05	0.00017	CcSEcCtD
Aprepitant—Dyspnoea—Gabapentin—epilepsy syndrome	1.44e-05	0.00017	CcSEcCtD
Aprepitant—Hypertension—Topiramate—epilepsy syndrome	1.44e-05	0.00017	CcSEcCtD
Aprepitant—Somnolence—Gabapentin—epilepsy syndrome	1.43e-05	0.000169	CcSEcCtD
Aprepitant—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.43e-05	0.000169	CcSEcCtD
Aprepitant—Dyspepsia—Gabapentin—epilepsy syndrome	1.42e-05	0.000168	CcSEcCtD
Aprepitant—Chest pain—Topiramate—epilepsy syndrome	1.42e-05	0.000167	CcSEcCtD
Aprepitant—Arthralgia—Topiramate—epilepsy syndrome	1.42e-05	0.000167	CcSEcCtD
Aprepitant—Myalgia—Topiramate—epilepsy syndrome	1.42e-05	0.000167	CcSEcCtD
Aprepitant—Anxiety—Topiramate—epilepsy syndrome	1.41e-05	0.000167	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.41e-05	0.000166	CcSEcCtD
Aprepitant—Decreased appetite—Gabapentin—epilepsy syndrome	1.4e-05	0.000166	CcSEcCtD
Aprepitant—Discomfort—Topiramate—epilepsy syndrome	1.4e-05	0.000165	CcSEcCtD
Aprepitant—Urticaria—Pregabalin—epilepsy syndrome	1.4e-05	0.000165	CcSEcCtD
Aprepitant—Asthenia—Valproic Acid—epilepsy syndrome	1.4e-05	0.000165	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.39e-05	0.000165	CcSEcCtD
Aprepitant—Fatigue—Gabapentin—epilepsy syndrome	1.39e-05	0.000164	CcSEcCtD
Aprepitant—Body temperature increased—Pregabalin—epilepsy syndrome	1.39e-05	0.000164	CcSEcCtD
Aprepitant—Abdominal pain—Pregabalin—epilepsy syndrome	1.39e-05	0.000164	CcSEcCtD
Aprepitant—Dry mouth—Topiramate—epilepsy syndrome	1.39e-05	0.000164	CcSEcCtD
Aprepitant—Constipation—Gabapentin—epilepsy syndrome	1.38e-05	0.000163	CcSEcCtD
Aprepitant—Pain—Gabapentin—epilepsy syndrome	1.38e-05	0.000163	CcSEcCtD
Aprepitant—Pruritus—Valproic Acid—epilepsy syndrome	1.38e-05	0.000163	CcSEcCtD
Aprepitant—Confusional state—Topiramate—epilepsy syndrome	1.37e-05	0.000162	CcSEcCtD
Aprepitant—Oedema—Topiramate—epilepsy syndrome	1.36e-05	0.00016	CcSEcCtD
Aprepitant—Infection—Topiramate—epilepsy syndrome	1.35e-05	0.000159	CcSEcCtD
Aprepitant—Shock—Topiramate—epilepsy syndrome	1.34e-05	0.000158	CcSEcCtD
Aprepitant—Diarrhoea—Valproic Acid—epilepsy syndrome	1.33e-05	0.000157	CcSEcCtD
Aprepitant—Nervous system disorder—Topiramate—epilepsy syndrome	1.33e-05	0.000157	CcSEcCtD
Aprepitant—Feeling abnormal—Gabapentin—epilepsy syndrome	1.33e-05	0.000157	CcSEcCtD
Aprepitant—Thrombocytopenia—Topiramate—epilepsy syndrome	1.33e-05	0.000157	CcSEcCtD
Aprepitant—Tachycardia—Topiramate—epilepsy syndrome	1.33e-05	0.000156	CcSEcCtD
Aprepitant—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.32e-05	0.000156	CcSEcCtD
Aprepitant—Skin disorder—Topiramate—epilepsy syndrome	1.32e-05	0.000156	CcSEcCtD
Aprepitant—Hyperhidrosis—Topiramate—epilepsy syndrome	1.31e-05	0.000155	CcSEcCtD
Aprepitant—Hypersensitivity—Pregabalin—epilepsy syndrome	1.3e-05	0.000153	CcSEcCtD
Aprepitant—Anorexia—Topiramate—epilepsy syndrome	1.29e-05	0.000153	CcSEcCtD
Aprepitant—Dizziness—Valproic Acid—epilepsy syndrome	1.29e-05	0.000152	CcSEcCtD
Aprepitant—Urticaria—Gabapentin—epilepsy syndrome	1.28e-05	0.000151	CcSEcCtD
Aprepitant—Abdominal pain—Gabapentin—epilepsy syndrome	1.28e-05	0.000151	CcSEcCtD
Aprepitant—Body temperature increased—Gabapentin—epilepsy syndrome	1.28e-05	0.000151	CcSEcCtD
Aprepitant—Hypotension—Topiramate—epilepsy syndrome	1.27e-05	0.00015	CcSEcCtD
Aprepitant—Asthenia—Pregabalin—epilepsy syndrome	1.26e-05	0.000149	CcSEcCtD
Aprepitant—Pruritus—Pregabalin—epilepsy syndrome	1.25e-05	0.000147	CcSEcCtD
Aprepitant—Vomiting—Valproic Acid—epilepsy syndrome	1.24e-05	0.000146	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.24e-05	0.000146	CcSEcCtD
Aprepitant—Insomnia—Topiramate—epilepsy syndrome	1.23e-05	0.000145	CcSEcCtD
Aprepitant—Rash—Valproic Acid—epilepsy syndrome	1.23e-05	0.000145	CcSEcCtD
Aprepitant—Dermatitis—Valproic Acid—epilepsy syndrome	1.23e-05	0.000145	CcSEcCtD
Aprepitant—Headache—Valproic Acid—epilepsy syndrome	1.22e-05	0.000144	CcSEcCtD
Aprepitant—Paraesthesia—Topiramate—epilepsy syndrome	1.22e-05	0.000144	CcSEcCtD
Aprepitant—Dyspnoea—Topiramate—epilepsy syndrome	1.21e-05	0.000143	CcSEcCtD
Aprepitant—Somnolence—Topiramate—epilepsy syndrome	1.21e-05	0.000143	CcSEcCtD
Aprepitant—Diarrhoea—Pregabalin—epilepsy syndrome	1.2e-05	0.000142	CcSEcCtD
Aprepitant—Dyspepsia—Topiramate—epilepsy syndrome	1.2e-05	0.000141	CcSEcCtD
Aprepitant—Hypersensitivity—Gabapentin—epilepsy syndrome	1.19e-05	0.00014	CcSEcCtD
Aprepitant—Decreased appetite—Topiramate—epilepsy syndrome	1.18e-05	0.000139	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.17e-05	0.000138	CcSEcCtD
Aprepitant—Fatigue—Topiramate—epilepsy syndrome	1.17e-05	0.000138	CcSEcCtD
Aprepitant—Dizziness—Pregabalin—epilepsy syndrome	1.16e-05	0.000137	CcSEcCtD
Aprepitant—Constipation—Topiramate—epilepsy syndrome	1.16e-05	0.000137	CcSEcCtD
Aprepitant—Pain—Topiramate—epilepsy syndrome	1.16e-05	0.000137	CcSEcCtD
Aprepitant—Asthenia—Gabapentin—epilepsy syndrome	1.16e-05	0.000137	CcSEcCtD
Aprepitant—Nausea—Valproic Acid—epilepsy syndrome	1.16e-05	0.000137	CcSEcCtD
Aprepitant—Pruritus—Gabapentin—epilepsy syndrome	1.14e-05	0.000135	CcSEcCtD
Aprepitant—Vomiting—Pregabalin—epilepsy syndrome	1.12e-05	0.000132	CcSEcCtD
Aprepitant—Feeling abnormal—Topiramate—epilepsy syndrome	1.12e-05	0.000132	CcSEcCtD
Aprepitant—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.11e-05	0.000131	CcSEcCtD
Aprepitant—Rash—Pregabalin—epilepsy syndrome	1.11e-05	0.000131	CcSEcCtD
Aprepitant—Dermatitis—Pregabalin—epilepsy syndrome	1.11e-05	0.000131	CcSEcCtD
Aprepitant—Diarrhoea—Gabapentin—epilepsy syndrome	1.1e-05	0.00013	CcSEcCtD
Aprepitant—Headache—Pregabalin—epilepsy syndrome	1.1e-05	0.00013	CcSEcCtD
Aprepitant—Urticaria—Topiramate—epilepsy syndrome	1.08e-05	0.000127	CcSEcCtD
Aprepitant—Abdominal pain—Topiramate—epilepsy syndrome	1.07e-05	0.000127	CcSEcCtD
Aprepitant—Body temperature increased—Topiramate—epilepsy syndrome	1.07e-05	0.000127	CcSEcCtD
Aprepitant—Dizziness—Gabapentin—epilepsy syndrome	1.07e-05	0.000126	CcSEcCtD
Aprepitant—Nausea—Pregabalin—epilepsy syndrome	1.05e-05	0.000123	CcSEcCtD
Aprepitant—Vomiting—Gabapentin—epilepsy syndrome	1.03e-05	0.000121	CcSEcCtD
Aprepitant—Rash—Gabapentin—epilepsy syndrome	1.02e-05	0.00012	CcSEcCtD
Aprepitant—Dermatitis—Gabapentin—epilepsy syndrome	1.02e-05	0.00012	CcSEcCtD
Aprepitant—Headache—Gabapentin—epilepsy syndrome	1.01e-05	0.000119	CcSEcCtD
Aprepitant—Hypersensitivity—Topiramate—epilepsy syndrome	1e-05	0.000118	CcSEcCtD
Aprepitant—Asthenia—Topiramate—epilepsy syndrome	9.74e-06	0.000115	CcSEcCtD
Aprepitant—Pruritus—Topiramate—epilepsy syndrome	9.61e-06	0.000113	CcSEcCtD
Aprepitant—Nausea—Gabapentin—epilepsy syndrome	9.59e-06	0.000113	CcSEcCtD
Aprepitant—Diarrhoea—Topiramate—epilepsy syndrome	9.29e-06	0.00011	CcSEcCtD
Aprepitant—Dizziness—Topiramate—epilepsy syndrome	8.98e-06	0.000106	CcSEcCtD
Aprepitant—Vomiting—Topiramate—epilepsy syndrome	8.63e-06	0.000102	CcSEcCtD
Aprepitant—Rash—Topiramate—epilepsy syndrome	8.56e-06	0.000101	CcSEcCtD
Aprepitant—Dermatitis—Topiramate—epilepsy syndrome	8.55e-06	0.000101	CcSEcCtD
Aprepitant—Headache—Topiramate—epilepsy syndrome	8.51e-06	0.0001	CcSEcCtD
Aprepitant—Nausea—Topiramate—epilepsy syndrome	8.07e-06	9.52e-05	CcSEcCtD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.44e-06	7.7e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—COX3—epilepsy syndrome	3.4e-06	7.61e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	3.34e-06	7.48e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	3.32e-06	7.43e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	3.31e-06	7.4e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	3.31e-06	7.4e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—epilepsy syndrome	3.3e-06	7.38e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.29e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.29e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.29e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.29e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.29e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.29e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AQP1—epilepsy syndrome	3.25e-06	7.26e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL2—epilepsy syndrome	3.23e-06	7.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	3.23e-06	7.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PFKL—epilepsy syndrome	3.23e-06	7.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	3.23e-06	7.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	3.23e-06	7.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	3.23e-06	7.22e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	3.23e-06	7.21e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	3.22e-06	7.2e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	3.21e-06	7.18e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GBE1—epilepsy syndrome	3.21e-06	7.18e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	3.21e-06	7.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.15e-06	7.05e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NT5E—epilepsy syndrome	3.14e-06	7.02e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALAD—epilepsy syndrome	3.14e-06	7.02e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.14e-06	7.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.13e-06	7.01e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	3.02e-06	6.75e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.01e-06	6.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.01e-06	6.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.01e-06	6.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.01e-06	6.72e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	2.99e-06	6.7e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	2.99e-06	6.7e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—UPB1—epilepsy syndrome	2.95e-06	6.6e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NEU1—epilepsy syndrome	2.95e-06	6.6e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ATIC—epilepsy syndrome	2.95e-06	6.6e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	2.94e-06	6.57e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	2.93e-06	6.56e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	2.93e-06	6.56e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	2.93e-06	6.55e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FGF2—epilepsy syndrome	2.92e-06	6.53e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	2.89e-06	6.47e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ADSL—epilepsy syndrome	2.87e-06	6.42e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NT5E—epilepsy syndrome	2.86e-06	6.4e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALAD—epilepsy syndrome	2.86e-06	6.4e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	2.84e-06	6.35e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GLUL—epilepsy syndrome	2.81e-06	6.29e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.79e-06	6.25e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.79e-06	6.25e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.79e-06	6.23e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	2.76e-06	6.18e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	2.75e-06	6.16e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	2.74e-06	6.14e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GBE1—epilepsy syndrome	2.74e-06	6.14e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—BCHE—epilepsy syndrome	2.74e-06	6.13e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	2.73e-06	6.1e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	2.73e-06	6.1e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RELA—epilepsy syndrome	2.71e-06	6.06e-05	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AKT1—epilepsy syndrome	2.71e-06	6.06e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.68e-06	6e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	2.67e-06	5.97e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MTOR—epilepsy syndrome	2.66e-06	5.94e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.63e-06	5.87e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADSL—epilepsy syndrome	2.62e-06	5.85e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	2.62e-06	5.85e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	2.59e-06	5.79e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	2.58e-06	5.78e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	2.58e-06	5.77e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TH—epilepsy syndrome	2.58e-06	5.77e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GLUL—epilepsy syndrome	2.57e-06	5.74e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	2.52e-06	5.63e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	2.51e-06	5.61e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.51e-06	5.61e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.49e-06	5.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.49e-06	5.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.49e-06	5.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.49e-06	5.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.49e-06	5.57e-05	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.47e-06	5.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NT5E—epilepsy syndrome	2.45e-06	5.47e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALAD—epilepsy syndrome	2.45e-06	5.47e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP3—epilepsy syndrome	2.44e-06	5.47e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.41e-06	5.39e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	2.39e-06	5.35e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—JUN—epilepsy syndrome	2.37e-06	5.31e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.36e-06	5.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.33e-06	5.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.33e-06	5.22e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.33e-06	5.21e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.32e-06	5.18e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—epilepsy syndrome	2.31e-06	5.17e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.29e-06	5.12e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.28e-06	5.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.28e-06	5.09e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.28e-06	5.09e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.28e-06	5.09e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.27e-06	5.07e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.27e-06	5.07e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—epilepsy syndrome	2.24e-06	5.01e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.24e-06	5e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.2e-06	4.91e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.19e-06	4.9e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.19e-06	4.9e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.15e-06	4.81e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.15e-06	4.81e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SRC—epilepsy syndrome	2.13e-06	4.76e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.12e-06	4.75e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.12e-06	4.73e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.12e-06	4.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.11e-06	4.73e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.09e-06	4.68e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.07e-06	4.64e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.07e-06	4.63e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.07e-06	4.63e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.07e-06	4.63e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.07e-06	4.62e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.01e-06	4.5e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.99e-06	4.45e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.99e-06	4.45e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.98e-06	4.43e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.95e-06	4.37e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.94e-06	4.33e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.93e-06	4.31e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GPX1—epilepsy syndrome	1.92e-06	4.29e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.89e-06	4.23e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.89e-06	4.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.89e-06	4.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.89e-06	4.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.88e-06	4.2e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.87e-06	4.18e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TH—epilepsy syndrome	1.86e-06	4.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.85e-06	4.14e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.8e-06	4.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.8e-06	4.03e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.79e-06	4.01e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.78e-06	3.98e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.77e-06	3.95e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.77e-06	3.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.76e-06	3.94e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.73e-06	3.86e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.69e-06	3.79e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.69e-06	3.77e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.68e-06	3.77e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.66e-06	3.72e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.65e-06	3.69e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.65e-06	3.68e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.64e-06	3.68e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.63e-06	3.65e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.62e-06	3.63e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.62e-06	3.63e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.62e-06	3.62e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.61e-06	3.61e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.56e-06	3.48e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.55e-06	3.48e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.54e-06	3.44e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.53e-06	3.43e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.53e-06	3.43e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.51e-06	3.37e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.49e-06	3.34e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.48e-06	3.31e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.47e-06	3.3e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.46e-06	3.27e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.45e-06	3.23e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.44e-06	3.22e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TH—epilepsy syndrome	1.44e-06	3.22e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.42e-06	3.17e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.42e-06	3.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.4e-06	3.14e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.4e-06	3.14e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.4e-06	3.13e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.4e-06	3.12e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.39e-06	3.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.39e-06	3.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.36e-06	3.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.36e-06	3.05e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.33e-06	2.98e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—epilepsy syndrome	1.32e-06	2.96e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.32e-06	2.95e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TH—epilepsy syndrome	1.31e-06	2.94e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.29e-06	2.89e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.29e-06	2.89e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.26e-06	2.83e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.26e-06	2.82e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.22e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.2e-06	2.69e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.2e-06	2.68e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.19e-06	2.67e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.19e-06	2.67e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.19e-06	2.65e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.15e-06	2.58e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.14e-06	2.55e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	2.53e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.13e-06	2.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TH—epilepsy syndrome	1.12e-06	2.51e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.11e-06	2.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.11e-06	2.47e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.1e-06	2.45e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.08e-06	2.42e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.08e-06	2.42e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.08e-06	2.41e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.07e-06	2.4e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.05e-06	2.35e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.02e-06	2.29e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—epilepsy syndrome	9.79e-07	2.19e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.72e-07	2.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AGT—epilepsy syndrome	9.41e-07	2.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	9.37e-07	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—epilepsy syndrome	9.34e-07	2.09e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	9.26e-07	2.07e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAT—epilepsy syndrome	9.25e-07	2.07e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—epilepsy syndrome	9.22e-07	2.06e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BCHE—epilepsy syndrome	9.22e-07	2.06e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	8.99e-07	2.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.79e-07	1.97e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.7e-07	1.94e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TH—epilepsy syndrome	8.67e-07	1.94e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AGT—epilepsy syndrome	8.58e-07	1.92e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—epilepsy syndrome	8.41e-07	1.88e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—epilepsy syndrome	8.36e-07	1.87e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	8.17e-07	1.83e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—epilepsy syndrome	7.92e-07	1.77e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AGT—epilepsy syndrome	7.33e-07	1.64e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.23e-07	1.62e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—epilepsy syndrome	7.22e-07	1.62e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—epilepsy syndrome	7.22e-07	1.61e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—epilepsy syndrome	7.18e-07	1.61e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.14e-07	1.6e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.94e-07	1.55e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—epilepsy syndrome	6.58e-07	1.47e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.45e-07	1.44e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.32e-07	1.41e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—epilepsy syndrome	6.17e-07	1.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.76e-07	1.29e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—epilepsy syndrome	5.68e-07	1.27e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.66e-07	1.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.63e-07	1.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.54e-07	1.24e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.92e-07	1.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.76e-07	1.07e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.34e-07	9.71e-06	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.11e-07	9.18e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.8e-07	8.5e-06	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.18e-07	7.1e-06	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.9e-07	6.47e-06	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.47e-07	5.53e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.91e-07	4.27e-06	CbGpPWpGaD
